Literature DB >> 20399136

New developments in the discovery of small molecule Hedgehog pathway antagonists.

Martin R Tremblay1, Karen McGovern, Margaret A Read, Alfredo C Castro.   

Abstract

The Hedgehog (Hh) signaling pathway is crucial for normal embryonic development. Aberrant Hh signaling is implicated in numerous pathologic conditions including proliferative diseases such as cancer. During the past decade, academic and industrial research efforts have resulted in the discovery of a variety of Hh pathway antagonists. This review focuses on the most recent advances in this field with particular emphasis on the medicinal chemistry approaches used to discover these Hh antagonists. While most of the small molecule modulators of the Hh pathway were discovered through screening and subsequent medicinal chemistry, a number of them originated from rational design or natural products. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399136     DOI: 10.1016/j.cbpa.2010.03.016

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  12 in total

1.  Arsenic: a potentially useful poison for Hedgehog-driven cancers.

Authors:  G Praveen Raju
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 2.  Investigational Notch and Hedgehog inhibitors--therapies for cardiovascular disease.

Authors:  Eileen M Redmond; Shaunta Guha; Dermot Walls; Paul A Cahill
Journal:  Expert Opin Investig Drugs       Date:  2011-10-18       Impact factor: 6.206

3.  Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.

Authors:  Emanuela Heller; Michelle A Hurchla; Jingyu Xiang; Xinming Su; Sara Chen; Jochen Schneider; Kyu-Sang Joeng; Marcos Vidal; Leah Goldberg; Hongju Deng; Mary C Hornick; Julie L Prior; David Piwnica-Worms; Fanxin Long; Ross Cagan; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2011-12-20       Impact factor: 12.701

4.  Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities.

Authors:  Mariella Gruber Filbin; Sukriti K Dabral; Maria F Pazyra-Murphy; Shakti Ramkissoon; Andrew L Kung; Ekaterina Pak; Jarom Chung; Matthew A Theisen; Yanping Sun; Yoko Franchetti; Yu Sun; David S Shulman; Navid Redjal; Barbara Tabak; Rameen Beroukhim; Qi Wang; Jean Zhao; Marion Dorsch; Silvia Buonamici; Keith L Ligon; Joseph F Kelleher; Rosalind A Segal
Journal:  Nat Med       Date:  2013-09-29       Impact factor: 53.440

5.  Glucocorticoid compounds modify smoothened localization and hedgehog pathway activity.

Authors:  Yu Wang; Lance Davidow; Anthony C Arvanites; Joel Blanchard; Kelvin Lam; Ke Xu; Vatsal Oza; Jin Woo Yoo; Jessica M Y Ng; Tom Curran; Lee L Rubin; Andrew P McMahon
Journal:  Chem Biol       Date:  2012-08-24

6.  CD200-expressing human basal cell carcinoma cells initiate tumor growth.

Authors:  Chantal S Colmont; Antisar Benketah; Simon H Reed; Nga V Hawk; William G Telford; Manabu Ohyama; Mark C Udey; Carole L Yee; Jonathan C Vogel; Girish K Patel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-04       Impact factor: 11.205

7.  2-Chloro-N-(4-chloro-3-iodo-phen-yl)-4-(methyl-sulfon-yl)benzamide.

Authors:  Dao-Cai Wang; Hang Song; Chang Yang; Wen-Cai Huang; Shun Yao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-21

8.  The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.

Authors:  Tapati Mazumdar; Jennifer DeVecchio; Akwasi Agyeman; Ting Shi; Janet A Houghton
Journal:  Oncotarget       Date:  2011-08

9.  Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies.

Authors:  Chris Dockendorff; Marek M Nagiec; Michel Weïwer; Sara Buhrlage; Amal Ting; Partha P Nag; Andrew Germain; Han-Je Kim; Willmen Youngsaye; Christina Scherer; Melissa Bennion; Linlong Xue; Benjamin Z Stanton; Timothy A Lewis; Lawrence Macpherson; Michelle Palmer; Michael A Foley; José R Perez; Stuart L Schreiber
Journal:  ACS Med Chem Lett       Date:  2012-08-30       Impact factor: 4.345

10.  Hedgehog pathway inhibitors - current status and future prospects.

Authors:  Asfandyar Sheikh; Arsalan Ahmad Alvi; Hafiz Muhammad Aslam; Abdul Haseeb
Journal:  Infect Agent Cancer       Date:  2012-11-01       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.